Skip to main content
Main navigation
About Us
Policy & Advocacy
Innovation
Quality
Global Reach
Organization
Resources
Library
Press Releases
News Releases
Interviews
Videos
P.A.G.E
UCPMP
Find resources, news, and articles related to policy issues and scientific innovation.
Loading...
Articles
Articles
Articles
Publications
External Studies
Newsletters
Filter by Year:
All Years
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
Blog
2025-07-22
Sustainability: The New Pillar of Indian Pharma by Sudarshan Jain
Read More
Blog
2025-05-19
Space: Pharma’s Next Frontier?
Read More
Blog
2025-01-27
Indo-US Pharma Alliance: Time to Step Up
Read More
Blog
2024-07-14
Next Decade Will Be Brighter for India: Pankaj Patel
Read More
Blog
2024-07-13
To Improve Quality, Build a Strong Culture: Dilip Shanghvi
Read More
Blog
2024-07-12
Quality Is About Patient Safety, Not Just Compliance: GV Prasad
Read More
Blog
2022-12-21
Indian Pharma Set for Volume-to-Value Shift
Read More
Blog
2022-12-21
India’s Green Manufacturing Journey in Pharma
Read More
Blog
2022-12-19
Pharma Needs Govt Push for Innovation: Experts
Read More
Blog
2022-12-15
Raw Material Costs Pressuring Drugmakers: Hamied
Read More
Blog
2022-11-20
Post-COVID, Industry-Academia Synergy Grows: PSA
Read More
Blog
2022-08-15
Pharma Industry a Pillar of India’s Growth
Read More
Blog
2022-07-04
Quality Crucial for Indian Pharma’s Global Edge
Read More
Blog
2022-06-27
Exempt Low-Cost Drugs from Price Cap: IPA
Read More
Blog
2022-04-19
Indian Pharma Poised to Leapfrog into the Future
Read More
Blog
2022-03-11
Boost Domestic API Manufacturing: Sudarshan Jain
Read More
Blog
2022-03-02
Where Is Indian Pharma Headed?
Read More
Blog
2022-02-26
IPA Summit Spotlights Quality Best Practices
Read More
Blog
2022-02-25
IPA’s Global Summit Shares Sustainability Practices
Read More
Blog
2022-02-25
IPA: Spare Cheap Drugs from Price Control
Read More
Blog
2022-02-25
Digital Tech Key to Sustainable Pharma Growth
Read More
Blog
2022-02-25
IPA Hosts Global Summit on Quality & Sustainability
Read More
Blog
2022-02-25
Global Summit Pushes Quality Pharma, Sustainably
Read More
Blog
2022-02-24
Industry Must Uphold Quality: S Aparna
Read More
Blog
2022-02-21
India’s Exports to UAE Set to Grow Under Trade Pact
Read More
Blog
2022-02-10
Vaccines & Biologics: Pharma’s New Frontier
Read More
Blog
2022-02-08
Dolo-650: How Micro Labs Hit Gold in COVID
Read More
Blog
2022-02-02
Budget Health Allocations Draw Mixed Reactions
Read More
Blog
2022-01-30
Sudarshan Jain: Embrace Tech and Learn Fast
Read More
Blog
2022-01-27
Budget 2022 Should Fuel Pharma Innovation
Read More
Blog
2022-01-27
Pharma Seeks R&D Incentives in Budget
Read More
Blog
2022-01-24
Innovation & Tech to Elevate Indian Pharma in 2022
Read More
Blog
2022-01-04
Pharma Industry to Grow 9–11% in FY22: Icra
Read More
Blog
2021-12-27
Pharma’s Pandemic Response and Year Ahead
Read More
Blog
2021-12-25
Predictions 2022: Pharma’s Post-COVID Future
Read More
Blog
2021-12-24
Govt’s Draft R&D Policy a Boost for Innovation
Read More
Blog
2021-11-19
Global Innovation Summit Charts Pharma’s Path
Read More
Blog
2021-11-18
PM Modi: India Is ‘Pharmacy of the World’
Read More
Blog
2021-11-18
India Aiming for $130B Pharma Industry by 2030: Minister
Read More
Blog
2021-11-18
PM Modi: Over $12 Billion in Foreign Investment in Healthcare; India Now Called the 'Pharmacy of the World'
Read More
Blog
2021-11-18
Global Trust Makes India ‘Pharmacy of the World’: PM
Read More
Blog
2021-11-18
Initiate, Innovate, Make in India for the World: PM to Pharma Industry
Read More
Blog
2021-11-18
India Exported 65M COVID Vaccine Doses in 2021: PM
Read More
Blog
2021-11-18
India Aims to Lead in Drug Ecosystem: PM
Read More
Blog
2021-11-18
PM: Pharma Rose During COVID, Must Focus on Raw Materials
Read More
Blog
2021-11-18
COVID Brought Sharp Focus To India's Pharma Sector: PM Modi
Read More
Blog
2021-11-18
PLI to Secure India’s Critical Drug Supplies: Mandaviya
Read More
Blog
2021-11-18
Boost API Manufacturing at Home: PM Modi
Read More
Blog
2021-10-18
India Called the 'Pharmacy of the World': PM Modi on Healthcare Sector
Read More
Blog
2021-10-18
Make in India & Make for the World: PM Modi at Global Pharma Innovation Summit
Read More
Blog
2021-10-04
Digital Innovation Critical for Indian Pharma Growth: Sudarshan Jain
Read More
Blog
2021-10-04
IPA Appoints Samir Mehta as President, Samina Hamied as Vice President
Read More
Blog
2021-09-23
Overcoming Vaccine Hesitancy: Convincing the Undecideds
Read More
Blog
2021-08-20
Generic & Biosimilar Industry Focused on Expanding Reach Through Emerging and Traditional Modalities
Read More
Blog
2021-08-20
IP Alliance and CSIR Host First Pharmaceutical Innovation Exchange Forum
Read More
Blog
2021-08-18
Regulators Must Align to Approve Generics and Biosimilars: Sudarshan Jain
Read More
Blog
2021-08-17
COVID-19 and Beyond: Focusing on a Patient-Centric Culture
Read More
Blog
2021-08-15
India’s Pharma Journey: From Non-Existence to Global Leadership
Read More
Blog
2021-08-06
IGBA Advocates Regulatory Reform for Generic and Biosimilar Industry
Read More
Blog
2021-07-27
Indian Pharma Industry Ready to Embrace Digitalization: IGBA
Read More
Blog
2021-07-22
Favorable Policy Landscape Driving Pharma Innovation
Read More
Blog
2021-07-22
Everything Cannot Be Locally Produced: IGBA Chair
Read More
Blog
2021-07-15
Manufacturing Cooperation Key to Equitable Vaccine Access: Dr. Rajesh Jain
Read More
Blog
2021-07-07
IGBA Launches Whitepaper on Global Generic and Biosimilar Industry
Read More
Blog
2021-06-30
Global Vaccination Drive and Current Challenges
Read More
Blog
2021-06-23
Strategic Stockpiling of Essential Drugs Needed to Combat COVID-19
Read More
Blog
2021-06-18
COVID-19 Shows India’s Potential as an Innovation Hub: Sudarshan Jain
Read More
Blog
2021-06-15
The Indian Pharmaceutical Industry and Its Contributions
Read More
Blog
2021-06-08
Vaccine Copyright Reform: A Difficult but Necessary Path
Read More
Blog
2021-06-07
COVID-19 Unlocks New Opportunities for Indian Pharma: Sudarshan Jain
Read More
Blog
2021-06-06
Learning Never Stops in Pharma
Read More
Blog
2021-05-24
Building the Indian Pharmaceutical Innovation Ecosystem
Read More
Blog
2021-05-17
COVID-19 Tests the Limits of Indian Pharma
Read More
Blog
2021-05-17
Indian Pharma Supports COVID Vaccine Waivers, Calls for Tech Transfer
Read More
Blog
2021-05-06
China Flight Halts Could Disrupt Indian Pharma Supply Chains
Read More
Blog
2021-04-29
IPA’s Jain: 3–4 Weeks Needed to Meet Indian Drug Shortages
Read More
Blog
2021-04-26
Building Future-Ready Pharma Supply Chains
Read More
Blog
2021-04-21
Remdesivir Crunch Due to Bad Science and Politics: Former IMA President
Read More
Blog
2021-04-14
Pharma Needs Diverse and Resilient Supply Chains: Experts
Read More
Blog
2021-04-14
India Must Rise to the Challenge on COVID-19 Vaccines
Read More
Blog
2021-03-28
Patient-Centricity Must Guide the Pharma Sector
Read More
Blog
2021-03-25
PCI Launches Faculty–Industry Training Program to Prepare Industry-Ready Graduates
Read More
Blog
2021-03-22
Teachers Must Learn Drug Development Through Industry Exposure: Expert
Read More
Blog
2021-03-19
Dr. Reddy’s on Digitization and ‘Lights-Out’ Manufacturing Amid COVID-19
Read More
Blog
2021-03-18
Challenges and Opportunities Facing Indian Pharma
Read More
Blog
2021-02-25
Indian Pharma Must Become Self-Reliant in API Production: IPA
Read More
Blog
2021-02-22
India Pharma Forum Focuses on Patients and Pandemic Learnings
Read More
Blog
2021-02-18
Pharma Is a Jewel in India’s Crown With Long-Term Growth Potential
Read More
Blog
2021-01-28
Innovation and Collaboration to Help Indian Pharma Leapfrog Globally: Experts
Read More
Blog
2021-01-25
Back to Growth: Sudarshan Jain on the Future of Indian Pharma
Read More
Blog
2021-01-24
Union Budget 2021: Pandemic Underscores Need for Higher Healthcare Allocation
Read More
Blog
2021-01-23
Industry Shares Budget 2021–22 Expectations
Read More
Blog
2021-01-20
Drugmakers Hope New US Government Will View Them as Allies
Read More
Blog
2021-01-01
Pharma Leaders Reflect on COVID-19’s Impact on the Industry
Read More
Blog
2020-12-15
Emerging Technologies Reshaping Pharmaceutical Operations
Read More
Blog
2020-12-15
IPA Report: Pharma Social Initiatives Touched 15 Million Lives
Read More
Blog
2020-12-14
Beyond Business: IPA's Report on Social Contributions
Read More
Blog
2020-12-04
Indian Pharma: Committed to Quality and Patient-Centricity
Read More
Blog
2020-11-26
Is India Ready for the COVID Vaccine? Here’s What We Should Do
Read More
Blog
2020-11-23
Biden Presidency Could Impact Indian Pharma With High Demand, Tight Inspections
Read More
Blog
2020-11-23
India’s Telemedicine Market Set to Reach $5.5 Billion by 2025
Read More
Blog
2020-11-21
Global Preference Growing for Indian-Origin Generic Drugs: Prof. Misra
Read More
Blog
2020-10-23
Spotlight on Indian Pharma’s Resilience During the Pandemic
Read More
Blog
2020-10-19
Ensuring Employee Safety in the Pharma Sector
Read More
Blog
2020-10-06
Aatmanirbhar Bharat’s Pharma Sector Must Look Beyond Generics
Read More
Blog
2020-09-22
Pharmaceutical Quality: Why It Matters
Read More
Blog
2020-09-09
India’s Pharma Sector: A Blossoming Market
Read More
Blog
2020-09-09
EY–IPA Study: India’s Telemedicine Market to Hit $5.5 Billion by 2025
Read More
Blog
2020-09-02
Solving India’s Dependency on Chinese Pharma Imports
Read More
Blog
2020-08-26
Pharma Industry Calls for More Government Support
Read More
Blog
2020-08-24
Pharma 2030: Innovations in Packaging
Read More
Blog
2020-08-24
India Leads in Repurposing COVID Drugs to Safeguard Supply Chains
Read More
Blog
2020-08-20
NPPA Rejects IPA's Request for Across-the-Board Price Hike
Read More
Blog
2020-08-14
Reinforcing India’s Role as the 'Pharmacy of the World' Post-COVID
Read More
Blog
2020-08-11
India’s Pharma Sector: The Post-COVID Landscape
Read More
Blog
2020-08-10
How India Used Strategic Partnerships to Tackle COVID Challenges
Read More
Blog
2020-08-10
When Can You Get a COVID Vaccine? 5 Key Things to Know
Read More
Blog
2020-08-07
Cipla Collaborates With CSIR, IICT, ICMR on COVID-19 Treatment
Read More
Blog
2020-08-02
NPPA Approves 50% Hike on Heparin Prices Amid Cost Surge
Read More
Blog
2020-08-02
The Good Fight: How India United to Battle COVID-19
Read More
Blog
2020-07-27
Grant API Sector Infrastructure Status: IPA President Satish Reddy
Read More
Blog
2020-07-09
IPA–BCG: Future-Proofing Pharma Work With a 3-Part Maturity Model
Read More
Blog
2020-07-09
IPA Affirms Commitment to Quality Drug Supply in India and Worldwide
Read More
Blog
2020-03-02
India’s Meteoric Pharma Rise: Ensuring Quality and Safety
Read More
Blog
2020-02-28
From Cultural Tradition to Quality Focus: What Lies Ahead for Indian Pharma
Read More
Blog
2020-01-30
COVID May Disrupt Key Drug and Electronics Supply Chains: Indian Express
Read More
Blog
2020-01-28
Budget 2020: The Pharma Wishlist
Read More
Blog
2020-01-17
No Progress Yet on Uniform Marketing Code: IPA
Read More
Blog
2017-05-19
FE: Drug Price Control Could Make Cheap Medicines Expensive
Read More
Blog
2017-04-17
ET: The Chill Pill India Needs
Read More
Blog
2017-01-01
CPHI 2017: Trade Pacts and the Competition–Exclusivity Divide
Read More
Blog
2016-01-01
CPHI 2016: Licensing of Generics — Industry Needs and Expectations
Read More
Blog
2015-12-25
India Must Beware the Side Effects of Pacific Trade Agreements
Read More
Blog
2015-05-20
India Can’t Buy Into the American Pharma Narrative
Read More
Blog
2015-01-01
PharmAsia 2015: TPP’s Impact on the Indian Pharma Sector
Read More
Blog
2015-01-01
CPHI 2015: How Mega Trade Pacts Affect Global Pharma
Read More
Blog
2014-11-01
CPHI 2014: Innovation and Intellectual Property in Pharma
Read More
Blog
2014-02-28
Why Drug Price Controls Can Be Harmful to Public Health
Read More
Blog
2013-10-01
The Generic Drug Challenge Facing Indian Pharma
Read More
Blog
2013-10-01
CPHI 2013: Drug Regulatory Scrutiny in the Pharmaceutical Industry
Read More